Combinatorial DNMTs and EZH2 inhibition reprograms the H3K27me3 and DNAme-mediated onco-epigenome to suppress multiple myeloma proliferation

Comprehensive epigenomic studies in multiple myeloma (MM) that unravel the connections between major epigenetic regulators, their intertwined collaboration and the potential of combinatorial targeting remain limited. Utilizing ChIP-seq, ATAC-seq, RNA-seq, and DNA methylation (DNAme) data, we generated whole-genome chromatin annotations from normal plasma cells and MM patients, revealing epigenomic re-configuration affecting downstream genes involved in tumour growth and survival. Primary MM samples showed global DNA hypomethylation but site-specific hypermethylation was observed at transcription start sites, promoters, and enhancers. Moreover, increased deposition of H3K27me3 was observed in clinically relevant functional chromatin clusters. Combined EZH2 and DNMTs inhibition resulted in extensive epigenomic alterations activating apoptosis and cell cycle genes, leading to increased G2/M arrest and apoptosis in MM cell lines. Our findings provide novel insights into the role of epigenetic gene silencing in MM tumorigenesis and the interplay between the Polycomb repressive complex 2 and DNAme.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-08-27
DOI
https://doi.org/10.1038/s41598-025-17093-z
Citations
2
Primary Topic
Epigenetics and DNA Methylation
Type
article
Field-Weighted Citation Impact
1.61

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Combinatorial DNMTs and EZH2 inhibition reprograms the H3K27me3 and DNAme-mediated onco-epigenome to suppress multiple myeloma proliferation

Paul Theodor Pyl, José I. Martı́n-Subero, Elke De Bruyne, Antonia Kalushkova et al.
2 citations
Scientific Reports
Epigenetics and DNA Methylation
1.61
article

Combinatorial DNMTs and EZH2 inhibition reprograms the H3K27me3 and DNAme-mediated onco-epigenome to suppress multiple myeloma proliferation

Paul Theodor Pyl, José I. Martı́n-Subero, Elke De Bruyne, Antonia Kalushkova, Jian Jun Jin, Berta Garrido-Zabala, Alba Atienza Párraga, Louella Vasquez, Jan Komorowski, Anqi Ma, Helena Jernberg‐Wiklund, Klev Diamanti, Doroteya Raykova, Aron Skaftason, Patrick Nylund, Fredrik Öberg, Stefania Iliana Tziola
article en
2 citations

Abstract

Comprehensive epigenomic studies in multiple myeloma (MM) that unravel the connections between major epigenetic regulators, their intertwined collaboration and the potential of combinatorial targeting remain limited. Utilizing ChIP-seq, ATAC-seq, RNA-seq, and DNA methylation (DNAme) data, we generated whole-genome chromatin annotations from normal plasma cells and MM patients, revealing epigenomic re-configuration affecting downstream genes involved in tumour growth and survival. Primary MM samples showed global DNA hypomethylation but site-specific hypermethylation was observed at transcription start sites, promoters, and enhancers. Moreover, increased deposition of H3K27me3 was observed in clinically relevant functional chromatin clusters. Combined EZH2 and DNMTs inhibition resulted in extensive epigenomic alterations activating apoptosis and cell cycle genes, leading to increased G2/M arrest and apoptosis in MM cell lines. Our findings provide novel insights into the role of epigenetic gene silencing in MM tumorigenesis and the interplay between the Polycomb repressive complex 2 and DNAme.

Scientific ReportsVol. 15(1)
Institució Catalana de Recerca i Estudis Avançats (ES), Uppsala University (SE), Vrije Universiteit Brussel (BE), Swedish Collegium for Advanced Study (SE), Lund University (SE), Science for Life Laboratory (SE), Institute of Computer Science (PL), Medivir (Sweden) (SE), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Icahn School of Medicine at Mount Sinai (US), Polish Academy of Sciences (PL)
Amgen, Bristol-Myers Squibb, Celgene, European Commission, Cancerfonden, Karolinska Institutet, Knut och Alice Wallenbergs Stiftelse, Vetenskapsrådet, Uppsala Universitet, Science for Life Laboratory, National Institutes of Health
Zero hunger
Openalex Percentile: Top 15%
Epigenetics and DNA Methylation
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.